Uploaded October 2026 | Updated November 2026, 1 day ago
Inclusive clinical trials and research participation in low- and middle-income countries were central to this discussion. Speakers shared examples of regulatory reform, digital health records, and partnerships that could improve recruitment and research capacity. They highlighted patient safety, data protection, and community trust as foundations for generating evidence that reflected diverse populations.
Chair
• Rowland Illing, Amazon Web Services (AWS)
Speakers
• Anamaria Camargo, Hospital Sírio-Libanês
• Emer Cooke, European Medicines Agency (EMA)
• Jennifer Dent, BIO Ventures for Global Health
• Jeremy Farrar, PATH
• Abdullahi Sheikh, Konvergenz Network Solutions
Explore related sessions:
• Academic Responsibility - Societal Change and Global Development youtube.com/live/1ZwG9DGMb98
• AI in Biomedicine and Health: Balancing Innovation and Integrity youtube.com/live/qK-dL5w0IYk
The World Health Summit 2026 took place October 11–13 in Berlin and online, bringing together leaders and changemakers from science, politics, civil society, and the private sector to address key global health priorities.
Learn more: worldhealthsummit.org
────────────────────────
Chapters:
00:00 Introduction: Modernizing Clinical Trials
03:15 Jeremy Farrar: How Can Clinical Trials Become More Inclusive?
07:35 Why Does Diversity Matter in Clinical Research?
10:50 How Can Partnerships Expand Clinical Trial Access?
15:05 Kenya: How Can Digital Health Infrastructure Support Research?
20:10 European Medicines Agency: How Can Regulation Support Global Trials?
24:30 How Can Clinical Trials Become More Efficient?
26:55 What Can LMICs Contribute to Global Clinical Research?
28:55 Brazil: How Can National Policies Strengthen Clinical Trials?
33:45 Nigeria: How Can Public-Private Partnerships Advance Research?
36:30 How Can Clinical Trials Protect Patients and Ensure Equitable Access?
39:35 Kenya: What Does Nationwide Digital Health Transformation Require?
47:40 How Can Digital Health Records Support Clinical Research?
49:05 How Can International Regulatory Cooperation Improve Access?
53:50 What Still Needs to Change in Global Clinical Research?
58:00 How Can Digital Health Infrastructure Be Financed Sustainably?
1:03:20 What Role Should Governments and Industry Play in Clinical Trials?
1:09:25 Audience Q&A: How Can AI Accelerate Clinical Trials?
1:13:55 Audience Q&A: What Can Telemedicine Contribute to Clinical Research?
1:16:45 Audience Q&A: How Can Emerging Researchers Enter Clinical Trials?
1:20:30 Audience Q&A: Can AI Improve Clinical Trial Data Sharing?
1:24:20 Audience Q&A: How Can Science Better Inform Political Decisions?
1:26:40 Closing Reflections: The Future of Inclusive Clinical Trials
Inclusive clinical trials and research participation in low- and middle-income countries were central to this discussion. Speakers shared examples of regulatory reform, digital health records, and partnerships that could improve recruitment and research capacity. They highlighted patient safety, data protection, and community trust as foundations for generating evidence that reflected diverse populations.
Chair
• Rowland Illing, Amazon Web Services (AWS)
Speakers
• Anamaria Camargo, Hospital Sírio-Libanês
• Emer Cooke, European Medicines Agency (EMA)
• Jennifer Dent, BIO Ventures for Global Health
• Jeremy Farrar, PATH
• Abdullahi Sheikh, Konvergenz Network Solutions
Explore related sessions:
• Academic Responsibility - Societal Change and Global Development youtube.com/live/1ZwG9DGMb98
• AI in Biomedicine and Health: Balancing Innovation and Integrity youtube.com/live/qK-dL5w0IYk
The World Health Summit 2026 took place October 11–13 in Berlin and online, bringing together leaders and changemakers from science, politics, civil society, and the private sector to address key global health priorities.
Learn more: worldhealthsummit.org
────────────────────────
Chapters:
00:00 Introduction: Modernizing Clinical Trials
03:15 Jeremy Farrar: How Can Clinical Trials Become More Inclusive?
07:35 Why Does Diversity Matter in Clinical Research?
10:50 How Can Partnerships Expand Clinical Trial Access?
15:05 Kenya: How Can Digital Health Infrastructure Support Research?
20:10 European Medicines Agency: How Can Regulation Support Global Trials?
24:30 How Can Clinical Trials Become More Efficient?
26:55 What Can LMICs Contribute to Global Clinical Research?
28:55 Brazil: How Can National Policies Strengthen Clinical Trials?
33:45 Nigeria: How Can Public-Private Partnerships Advance Research?
36:30 How Can Clinical Trials Protect Patients and Ensure Equitable Access?
39:35 Kenya: What Does Nationwide Digital Health Transformation Require?
47:40 How Can Digital Health Records Support Clinical Research?
49:05 How Can International Regulatory Cooperation Improve Access?
53:50 What Still Needs to Change in Global Clinical Research?
58:00 How Can Digital Health Infrastructure Be Financed Sustainably?
1:03:20 What Role Should Governments and Industry Play in Clinical Trials?
1:09:25 Audience Q&A: How Can AI Accelerate Clinical Trials?
1:13:55 Audience Q&A: What Can Telemedicine Contribute to Clinical Research?
1:16:45 Audience Q&A: How Can Emerging Researchers Enter Clinical Trials?
1:20:30 Audience Q&A: Can AI Improve Clinical Trial Data Sharing?
1:24:20 Audience Q&A: How Can Science Better Inform Political Decisions?
1:26:40 Closing Reflections: The Future of Inclusive Clinical Trials










